Comparing glioblastoma and RRMS patients, we detected a decrease in KLRG1+CD4−CD8− Tc (Tc-I 30) in glioblastoma patients, also visible when comparing glioblastoma patients and controls (Fig. 5P). Here, KLRG1 is linked to glioblastoma.